Maria Moksnes Bjaanæs

5PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 25, 2026
DNA methylation and expression of MAPRE3 affect overall survival of early-stage non-small cell lung cancer patients.

|Dec 04, 2024
A two-phase epigenome-wide four-way gene-smoking interaction study of overall survival for early-stage non-small cell lung cancer.

Leyi Chen, Xiang Wang, Ning Xie

|Nov 21, 2022
A trans-omics assessment of gene-gene interaction in early-stage NSCLC.

Jiajin Chen, Yunjie Song, Yi Li

|Nov 04, 2022
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.

Henrik Horndalsveen, Tine Norman Alver, Astrid Marie Dalsgaard

|Dec 21, 2021
Epigenome-wide three-way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early-stage NSCLC.

Xinyu Ji, Lijuan Lin, Juanjuan Fan

Pageof 1

Frequent Collaborators

4 joint publications

Manel Esteller

4 joint publications

Ruyang Zhang

2 joint publications

Feng Chen

1 joint publications

Leyi Chen